psalexa
logo

In Vitro Diagnostic Market

Global In-Vitro Diagnostic (IVD) Market Size, Share, Development, Growth and Demand Forecast to 2023

Delivery : 24-72 Working Hours
Report Code: LS10210
Available Format:

Chapter 1. Research Background

1.1. Research Objectives

1.2. Market Definition

1.3. Research Scope

1.3.1. Market Segmentation by Product & Services

1.3.2. Market Segmentation by Technology

1.3.3. Market Segmentation by Application

1.3.4. Market Segmentation by End-Users

1.3.5. Market Segmentation by Geography

1.3.6. Analysis Period

1.3.7. Market Data Reporting Unit

1.3.7.1. Value

1.4. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.2. Primary Research

2.2.1. Breakdown of Primary Research Respondents

2.2.1.1. By region

2.2.1.2. By industry participants

2.2.1.3. By company type

2.3. Market Size Estimation

2.4. Market Breakdown and Data Triangulation

2.5. Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1. Market Segmentation

4.1.1. Overview by Product & Services

4.1.1.1. Reagents and kits

4.1.1.2. Instruments

4.1.1.3. Software & services

4.1.2. Overview by Technology

4.1.2.1. Clinical chemistry

4.1.2.1.1. Basic metabolic panel

4.1.2.1.2. Electrolyte panel

4.1.2.1.3. Liver panel

4.1.2.1.4. Lipid profile

4.1.2.1.5. Renal profile

4.1.2.1.6. Others

4.1.2.2. Hematology

4.1.2.3. Molecular diagnostics

4.1.2.3.1. Polymerase chain reaction (PCR)

4.1.2.3.2. Isothermal nucleic acid amplification technology (INAAT)

4.1.2.3.3. Microarray

4.1.2.3.4. Hybridization

4.1.2.3.5. DNA sequencing & next-generation sequencing

4.1.2.3.6. Others

4.1.2.4. Clinical microbiology

4.1.2.5. Immunoassay/immunochemistry

4.1.2.5.1. Enzyme-linked immunosorbent assay (ELISA)

4.1.2.5.2. Radioimmunoassay (RIA)

4.1.2.5.3. Rapid tests

4.1.2.5.4. Western blot

4.1.2.5.5. Enzyme-linked immunospot (Elispot) assay

4.1.2.6. Others

4.1.3. Overview by Application

4.1.3.1. Infectious disease

4.1.3.2. Oncology

4.1.3.3. Cardiology

4.1.3.4. Nephrology

4.1.3.5. Autoimmune disorders

4.1.3.6. HIV/AIDS

4.1.3.7. Others

4.1.4. Overview by End User

4.1.4.1. Laboratories

4.1.4.2. Hospitals

4.1.4.3. Academic institutes

4.1.4.4. Point-of-care testing

4.1.4.5. Others

4.2. Market Dynamics

4.2.1. Trends

4.2.2. Drivers

4.2.2.1. Impact analysis of drivers on market forecast

4.2.3. Restraints

4.2.3.1. Impact analysis of restraints on market forecast

4.2.4. Opportunities

4.3. Porter’s Five Forces Analysis

Chapter 5. Market Size and Forecast by Product & Services

5.1. In-Vitro Diagnostic Reagents and kits Market

5.2. In-Vitro Diagnostic Instruments Market

5.3. In-Vitro Diagnostic Software & services Market

Chapter 6. Market Size and Forecast by Technology

6.1. In-Vitro Diagnostic Clinical Chemistry Market

6.1.1. Clinical Chemistry Market, by Type

6.1.1.1. Basic metabolic panel

6.1.1.2. Basic metabolic panel

6.1.1.3. Electrolyte panel

6.1.1.4. Liver panel

6.1.1.5. Lipid profile

6.1.1.6. Renal profile

6.2. In-Vitro Diagnostic Hematology Market

6.3. In-Vitro Diagnostic Molecular Diagnostics Market

6.3.1. Molecular Diagnostics Market, by Type

6.3.1.1. Polymerase chain reaction (PCR)

6.3.1.2. Isothermal nucleic acid amplification technology (INAAT)

6.3.1.3. Microarray

6.3.1.4. Hybridization

6.3.1.5. DNA sequencing & next-generation sequencing

6.4. In-Vitro Diagnostic Clinical Microbiology Market

6.5. In-Vitro Diagnostic Immunoassay/Immunochemistry Market

6.5.1. Immunoassay/Immunochemistry Market, by Type

6.5.1.1. Enzyme-linked immunosorbent assay (ELISA)

6.5.1.2. Radioimmunoassay (RIA)

6.5.1.3. Rapid tests

6.5.1.4. Western blot

6.5.1.5. Enzyme-linked immunospot (Elispot) assay

Chapter 7. Market Size and Forecast by Application

7.1. In-Vitro Diagnostic Market for Infectious disease

7.2. In-Vitro Diagnostic Market for Oncology

7.3. In-Vitro Diagnostic Market for Cardiology

7.4. In-Vitro Diagnostic Market for Nephrology

7.5. In-Vitro Diagnostic Market for Autoimmune disorders

7.6. In-Vitro Diagnostic Market for HIV/AIDS

Chapter 8. Market Size and Forecast by End-User

8.1. In-Vitro Diagnostic Market in Laboratories

8.2. In-Vitro Diagnostic Market in Hospitals

8.3. In-Vitro Diagnostic Market in Academic institutes

8.4. In-Vitro Diagnostic Market in Point-of-care testing

Chapter 9. Market Size and Forecast by Geography

9.1. North America In-Vitro Diagnostic Market

9.1.1. By Product & Services

9.1.2. By Technology

9.1.3. By Application

9.1.4. By End-User

9.1.5. By Country – The U.S. and Canada

9.2. Europe In-Vitro Diagnostic Market

9.2.1. By Product & Services

9.2.2. By Technology

9.2.3. By Application

9.2.4. By End-User

9.2.5. By Country – The U.K., Germany, France, Italy, Spain and Rest of Europe

9.3. Asia-Pacific In-Vitro Diagnostic Market

9.3.1. By Product & Services

9.3.2. By Technology

9.3.3. By Application

9.3.4. By End-User

9.3.5. By Country – Japan, China, India and Rest of Asia-Pacific

9.4. Latin America In-Vitro Diagnostic Market

9.4.1. By Product & Services

9.4.2. By Technology

9.4.3. By Application

9.4.4. By End-User

9.4.5. By Country – Brazil and Rest of Latin America

9.5. Middle East & Africa In-Vitro Diagnostic Market

9.5.1. By Product & Services

9.5.2. By Technology

9.5.3. By Application

9.5.4. By End-User

Chapter 10. Competitive Landscape

10.1. Competitive Analysis of Key Players

10.2. Global Strategic Developments

Chapter 11. Company Profiles

11.1. Abbott Laboratories, Inc.

11.1.1. Business Overview

11.1.2. Product and Service Offerings

11.2. F. Hoffmann La-Roche AG

11.2.1. Business Overview

11.2.2. Product and Service Offerings

11.3. Johnson & Johnson

11.3.1. Business Overview

11.3.2. Product and Service Offerings

11.4. Bio-Rad Laboratories, Inc.

11.4.1. Business Overview

11.4.2. Product and Service Offerings

11.5. Siemens AG

11.5.1. Business Overview

11.5.2. Product and Service Offerings

11.6. Danaher Corporation

11.6.1. Business Overview

11.6.2. Product and Service Offerings

11.7. Becton, Dickinson and Company

11.7.1. Business Overview

11.7.2. Product and Service Offerings

11.8. Biomérieux SA

11.8.1. Business Overview

11.8.2. Product and Service Offerings

11.9. Thermofisher Scientific, Inc

11.9.1. Business Overview

11.9.2. Product and Service Offerings

11.10. Sysmex Corporation

11.10.1. Business Overview

11.10.2. Product and Service Offerings

Chapter 12. Appendix

12.1. Abbreviations

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry